Additional File 11 of A Novel Virtual Barcode Strategy for Accurate Panel-Wide Variant Calling in Circulating Tumor DNA

Leilei Wu,Qinfang Deng,Ze Xu,Songwen Zhou,Chao Li,Yixue Li

DOI: https://doi.org/10.6084/m9.figshare.12082248

2020-01-01

Abstract:Additional file 11. Table S2. (Table S2).

What problem does this paper attempt to address?

Additional File 13 of A Novel Virtual Barcode Strategy for Accurate Panel-Wide Variant Calling in Circulating Tumor DNA

Leilei Wu,Qinfang Deng,Ze Xu,Songwen Zhou,Chao Li,Yixue Li

DOI: https://doi.org/10.6084/m9.figshare.12082254

2020-01-01

Abstract:Additional file 13. Table S4. (Table S4).
A novel virtual barcode strategy for accurate panel-wide variant calling in circulating tumor DNA

Leilei Wu,Qinfang Deng,Ze Xu,Songwen Zhou,Chao Li,Yi-Xue Li

DOI: https://doi.org/10.1186/s12859-020-3412-2

IF: 3.307

2020-04-03

BMC Bioinformatics

Abstract:Background: Hybrid capture-based next-generation sequencing of DNA has been widely applied in the detection of circulating tumor DNA (ctDNA). Various methods have been proposed for ctDNA detection, but low-allelic-fraction (AF) variants are still a great challenge. In addition, no panel-wide calling algorithm is available, which hiders the full usage of ctDNA based 'liquid biopsy'. Thus, we developed the VBCALAVD (Virtual Barcode-based Calling Algorithm for Low Allelic Variant Detection) in silico to overcome these limitations. Results: Based on the understanding of the nature of ctDNA fragmentation, a novel platform-independent virtual barcode strategy was established to eliminate random sequencing errors by clustering sequencing reads into virtual families. Stereotypical mutant-family-level background artifacts were polished by constructing AF distributions. Three additional robust fine-tuning filters were obtained to eliminate stochastic mutant-family-level noises. The performance of our algorithm was validated using cell-free DNA reference standard samples (cfDNA RSDs) and normal healthy cfDNA samples (cfDNA controls). For the RSDs with AFs of 0.1, 0.2, 0.5, 1 and 5%, the mean F1 scores were 0.43 (0.25~0.56), 0.77, 0.92, 0.926 (0.86~1.0) and 0.89 (0.75~1.0), respectively, which indicates that the proposed approach significantly outperforms the published algorithms. Among controls, no false positives were detected. Meanwhile, characteristics of mutant-family-level noise and quantitative determinants of divergence between mutant-family-level noises from controls and RSDs were clearly depicted. Conclusions: Due to its good performance in the detection of low-AF variants, our algorithm will greatly facilitate the noninvasive panel-wide detection of ctDNA in research and clinical settings. The whole pipeline is available at https://github.com/zhaodalv/VBCALAVD.
Additional File 1 of Patient Specific Circulating Tumor DNA Fingerprints to Monitor Treatment Response Across Multiple Tumors

Jiaping Li,Wei Jiang,Jie Wei,Jianwei Zhang,Linbo Cai,Minjie Luo,Wenfeng Zhan,Weitao Sun,Shengzhou Wang,Linghua Wang,Chun Dai,Jun Li,Guan Wang,Jiping Wang,Qin Xu,Yanhong Deng

DOI: https://doi.org/10.6084/m9.figshare.12751329

2020-01-01

Abstract:Additional file 1: Table S1. Mutations of eight hotspot tumor genes in the pre-designed ctDNA panel.
Additional File 6 of Mapping Intron Retention Events Contributing to Complex Traits Using Splice Quantitative Trait Locus

Siyuan Wang,Wu H,Yongyan Zhao,Lu-Yao Wang,Xueying Guan,Ting Zhao

DOI: https://doi.org/10.6084/m9.figshare.23730859

2023-01-01

Abstract:Additional file 6: Table S5. Summary of primer sequences used in the study.
Additional File 5: of SeqCNV: a Novel Method for Identification of Copy Number Variations in Targeted Next-Generation Sequencing Data

Qi‐Fu Chen,Li Zhao,Yi Wang,Cao Ming,Violet Gelowani,Mingchu Xu,Agrawal Smriti,Yumei Li,Daiger Stephen,Gibbs Richard,Wang Fei,Rui Chen

DOI: https://doi.org/10.6084/m9.figshare.c.3708070_d5.v1

2017-01-01

Abstract:SepCNV results on WES data. As we did on retinitis pigmentosa data, considering multiple factors such as DNA quality, DNA extraction protocol and the possibly non-even reads distribution, we randomly selected three samples to pool together as control (NA19152, NA18973, and NA19206), and randomly select one sample as case (NA10847). (PDF 7Â kb)
Additional File 7: of CloneCNA: Detecting Subclonal Somatic Copy Number Alterations in Heterogeneous Tumor Samples from Whole-Exome Sequencing Data

Zhenhua Yu,Ao Li,Minghui Wang

DOI: https://doi.org/10.6084/m9.figshare.c.3622028_d3

2016-01-01

Abstract:Four amplified mutations in sample SA052. (XLS 23 kb)
Additional File 6 of CUBIC: an Atlas of Genetic Architecture Promises Directed Maize Improvement

Haijun Liu,Xiaqing Wang,Yingjie Xiao,Jingyun Luo,Feng Qiao,Wenyu Yang,Ruyang Zhang,Yijiang Meng,Jiamin Sun,Shijuan Yan,Yong Peng,Luyao Niu,Liumei Jian,Wei Song,Jiali Yan,Chunhui Li,Yanxin Zhao,Liu Ya,Marilyn L. Warburton,Jiuran Zhao,Jianbing Yan

DOI: https://doi.org/10.6084/m9.figshare.11719764

2020-01-01

Abstract:Additional file 6. Bin information across whole genome.
A Novel Approach to Detect Large Indels from Targeted Sequencing Data in Clinical Cancer Setting

Lijuan Chen,Caiping Chen,Dongling Chen,Qiuyi Zou,Gungwei Qin,Hui Kang,Ming Yao,Kai Wang

DOI: https://doi.org/10.1200/jco.2017.35.15_suppl.e13002

IF: 45.3

2017-01-01

Journal of Clinical Oncology

Abstract:e13002 Background: Next generation sequencing (NGS) technologies have already shown numerous advances to revolutionize our understanding of cancer genomic profiling and improve cancer treatments. There have been many NGS data analysis tools available for identification of different genomic alternations including short insertion and deletion (short indel, < 25 bp in general). However, detection of > 100 bp large indel (L-indel) from short reads (generally < 200 bp) remains a huge challenge. L-indels identified in genes like MET and FLT3 have proven a critical implication in cancer treatments. Moreover, there is an urgent need for an algorithm to validate L-indels generated by genomic modification systems like ZFN, TALENs and CRISPR/Cas9. Methods: A novel algorithm was developed for calling L-indels in targeted sequencing data as following: raw reads were first filtered by selecting high-quality ones and correcting wrong bases; a chunk of contig (unitig) was then assembled and aligned to reference genome; lastly, break point information was collected and L-indels were calculated. The algorithm was applied on the reads generated from NA12878 cell line and FFPE samples collected in our lab respectively on the Illumina platform. Validation were performed by PCR and Sanger sequencing. Results: 22 novel exonic L-indels (17 deletions and 5 insertions) were identified with a median size of 1,616 bp (range: 25-6,684 bp) from NA12878 sequencing data and 100% successfully confirmed by Sanger sequencing. In addition, 6 out of 9 reported L-indels were also found with the rest awaiting for further exploration. Strikingly, a 2,446 bp deletion on MSH6, encodes an important component in mismatch repair (MMR) system, was detected on a FFPE sample of a lung cancer adenocarcinoma, which prompted to consideration of MMR deficiency otherwise. Conclusions: We have developed and validated a novel and accurate method for NGS large indels detection dedicated for targeted sequencing data in clinical cancer setting. Equipment of this method will greatly increase the capability of comprehensively understanding genomic alterations from a single NGS-based assay, and provide more information for potential clinical use.
Additional File 4 of Clonal Evolution in Liver Cancer at Single-Cell and Single-Variant Resolution

Xianbin Su,Linan Zhao,Yi Shi,Rui Zhang,Qi Long,Shihao Bai,Qing Luo,Yingxin Lin,Xin Zou,Shila Ghazanfar,Kun Tao,Guoliang Yang,Lan Wang,Kunyan He,Xiaofang Cui,Jian He,Jiaoxiang Wu,Bo Han,Bin Yan,Biao Deng,Na Wang,Xin Li,Pengyi Yang,Shangwei Hou,Jingyong Sun,Jean Yee Hwa Yang,Jinhong Chen,Ze‐Guang Han

DOI: https://doi.org/10.6084/m9.figshare.13698268

2021-01-01

Abstract:Additional file 4: Table S2. Mutation sites and amplification primers for single-cell target sequencing. This table shows the full list of target sites and PCR primers used in single-cell target amplification for HCC1, HCC2, HCC9 and HCC8. The primer sequences include the adaptor sequences that can be used for downstream library preparation with illumina Nextera XT Index Kit and multi-plexed sequencing.
Additional File 3 of Features of Alternative Splicing in Stomach Adenocarcinoma and Their Clinical Implication: a Research Based on Massive Sequencing Data

Yuanyuan Zhang,Shengling Ma,Qian Niu,Yingjie Han,Xingyu Liu,Jie Jiang,Simiao Chen,Haolong Lin

DOI: https://doi.org/10.6084/m9.figshare.12858462

2020-01-01

Abstract:Additional file 3. All R code and annotations in the file Additional file 3 have also been submitted.
Figure S14 from Discovery and Features of an Alkylating Signature in Colorectal Cancer

Carino Gurjao,Rugang Zhong,Koichiro Haruki,Yvonne Y. Li,Liam F. Spurr,Henry Lee-Six,Brendan Reardon,Tomotaka Ugai,Xuehong Zhang,Andrew D. Cherniack,Mingyang Song,Eliezer M. Van Allen,Jeffrey A. Meyerhardt,Jonathan A. Nowak,Edward Giovannucci,Charles S. Fuchs,Kana Wu,Shuji Ogino,Marios Giannakis

DOI: https://doi.org/10.1158/2159-8290.22539917.v1

2023-01-01

Abstract:Supplemental Figure 14: Variant calling pipeline Overview of the variant calling pipeline as described in CGA WES Characterization pipeline (https://github.com/broadinstitute/CGA_Production_Analysis_Pipeline) developed at the Broad Institute of MIT and Harvard.
Additional File 4 of A Next-Generation Sequencing-Based Strategy Combining Microsatellite Instability and Tumor Mutation Burden for Comprehensive Molecular Diagnosis of Advanced Colorectal Cancer

Jian Xiao,Wenyun Li,Yan Huang,Mengli Huang,Shanshan Li,Xiaoqiang Zhai,Jing Zhao,Chan Gao,Wenzhuan Xie,Hao Qin,Shangli Cai,Yuezong Bai,Ping Lan,Yifeng Zou

DOI: https://doi.org/10.6084/m9.figshare.14228099

2021-01-01

Abstract:Additional file 4: Table S3. The molecular diagnostic result of 98 CRC patients.
Additional File 8: of Genomic Copy Number Variation Association Study in Caucasian Patients with Nonsyndromic Cryptorchidism

Yanping Wang,Jin Li,Thomas F. Kolon,Alicia Olivant Fisher,T. Ernesto Figueroa,Ahmad H. Bani-Hani,Jennifer Hagerty,R. Jiménez González,Paul H. Noh,Rosetta Chiavacci,Kisha Harden,Debra Abrams,Deborah L. Stabley,Cecilia Kim,Katia Sol‐Church,Hákon Hákonarson,Marcella Devoto,Julia Spencer Barthold

DOI: https://doi.org/10.6084/m9.figshare.c.3602216_d3

2016-01-01

Abstract:CNV calls for Group 2 controls passed sample QC. Each column in Additional file 8 represents CNV location, SNPs numbers contained within the CNV, the length of the CNV, copy number (cn) of the CNV call, sample id, the starting marker identifier and the ending marker identifier in the CNV, and confidence score in PennCNV calling. (XLSX 1952Â kb)
Additional File 2 of Characterizing Sensitivity and Coverage of Clinical WGS As a Diagnostic Test for Genetic Disorders

Yehuan Sun,Fengxia Liu,Chunna Fan,Yaoshen Wang,Lijie Song,Zhonghai Fang,Rui Han,Zhonghua Wang,Xiaodan Wang,Ziying Yang,Zhenpeng Xu,Jiguang Peng,Cheng Shi,Hongyun Zhang,Dong Wang,Hui Huang,Yun Li,Yanqun Le,Jian Sun,Zhiyu Peng

DOI: https://doi.org/10.6084/m9.figshare.14411573

2021-01-01

Abstract:Additional file 2. Supplementary Material.
Additional File 3 of CICERO: a Versatile Method for Detecting Complex and Diverse Driver Fusions Using Cancer RNA Sequencing Data

Liqing Tian,Yongjin Li,Michael N. Edmonson,Xin Zhou,Scott Newman,Clay McLeod,Andrew Thrasher,Yu Liu,Bo Tang,Michael Rusch,John Easton,Jing Ma,Eric Davis,Austyn Trull,J. Robert Michael,Karol Szlachta,Charles G. Mullighan,Suzanne J. Baker,James R. Downing,David W. Ellison,Jinghui Zhang

DOI: https://doi.org/10.6084/m9.figshare.12386237

2020-01-01

Abstract:Additional file 3. Additional tables. This file shows the results of false positive rate of different fusion detection methods based on the analysis of 80 cases that have both WGS and RNA-seq.
Copy number variation analysis based on AluScan sequences

Jian-Feng Yang,Xiao-Fan Ding,Lei Chen,Wai-Kin Mat,Michelle Zhi Xu,Jin-Fei Chen,Jian-Min Wang,Lin Xu,Wai-Sang Poon,Ava Kwong,Gilberto Ka-Kit Leung,Tze-Ching Tan,Chi-Hung Yu,Yue-Bin Ke,Xin-Yun Xu,Xiao-Yan Ke,Ronald CW Ma,Juliana CN Chan,Wei-Qing Wan,Li-Wei Zhang,Yogesh Kumar,Shui-Ying Tsang,Shao Li,Hong-Yang Wang,Hong Xue

DOI: https://doi.org/10.1186/s13336-014-0015-z

2014-01-01

Abstract:Background AluScan combines inter- Alu PCR using multiple Alu -based primers with opposite orientations and next-generation sequencing to capture a huge number of Alu -proximal genomic sequences for investigation. Its requirement of only sub-microgram quantities of DNA facilitates the examination of large numbers of samples. However, the special features of AluScan data rendered difficult the calling of copy number variation (CNV) directly using the calling algorithms designed for whole genome sequencing (WGS) or exome sequencing. Results In this study, an AluScanCNV package has been assembled for efficient CNV calling from AluScan sequencing data employing a Geary-Hinkley transformation (GHT) of read-depth ratios between either paired test-control samples, or between test samples and a reference template constructed from reference samples, to call the localized CNVs, followed by use of a GISTIC-like algorithm to identify recurrent CNVs and circular binary segmentation (CBS) to reveal large extended CNVs. To evaluate the utility of CNVs called from AluScan data, the AluScans from 23 non-cancer and 38 cancer genomes were analyzed in this study. The glioma samples analyzed yielded the familiar extended copy-number losses on chromosomes 1p and 9. Also, the recurrent somatic CNVs identified from liver cancer samples were similar to those reported for liver cancer WGS with respect to a striking enrichment of copy-number gains in chromosomes 1q and 8q. When localized or recurrent CNV-features capable of distinguishing between liver and non-liver cancer samples were selected by correlation-based machine learning, a highly accurate separation of the liver and non-liver cancer classes was attained. Conclusions The results obtained from non-cancer and cancerous tissues indicated that the AluScanCNV package can be employed to call localized, recurrent and extended CNVs from AluScan sequences. Moreover, both the localized and recurrent CNVs identified by this method could be subjected to machine-learning selection to yield distinguishing CNV-features that were capable of separating between liver cancers and other types of cancers. Since the method is applicable to any human DNA sample with or without the availability of a paired control, it can also be employed to analyze the constitutional CNVs of individuals.
Additional File 8 of Breast Metastatic Tumors in Lung Can Be Substituted by Lung-Derived Malignant Cells Transformed by Alternative Splicing H19 Lncrna

Jin Biao Xu,Ji Cao,Ying Zhu,Yi He,Xin Jin,Mingguo Cao,Bing Mu Fang,Jean Paul Thiery,Zhou Weiyuan

DOI: https://doi.org/10.6084/m9.figshare.23265114

2023-01-01

Abstract:Additional file 8. Data file S1: PCR array plate layout.
Additional File 2: of Evaluation of Three Read-Depth Based CNV Detection Tools Using Whole-Exome Sequencing Data

Rutao Yao,Cheng Zhang,Tingting Yu,Li Niu,Xuyun Hu,Xiumin Wang,Jian Wang,Yiping Shen

DOI: https://doi.org/10.6084/m9.figshare.c.3861694_d2

2017-01-01

Abstract:Details of all 17ďťż1 variants detected by CMA. (XLS 90Â kb)
Additional File 5 of Genome-wide Characterization of Copy Number Variations in the Host Genome in Genetic Resistance to Marek’s Disease Using Next Generation Sequencing

Hao Bai,Yanghua He,Yi Ding,Qing Chu,Ling Lian,Eliyahu M. Heifetz,Ning Yang,Hans H. Cheng,Huanmin Zhang,Jilan Chen,Jiuzhou Song

DOI: https://doi.org/10.6084/m9.figshare.12667971

2020-01-01

Abstract:Additional file 5: Table S4. The detailed lists of all the GO terms and pathways from DAVID.
Additional File 10 of Assessing Reproducibility of Inherited Variants Detected with Short-Read Whole Genome Sequencing

Bohu Pan,Luyao Ren,Vitor Onuchic,Meijian Guan,Rebecca Kusko,Steve Bruinsma,Len Trigg,Andreas Scherer,Baitang Ning,Chaoyang Zhang,Christine Glidewell-Kenney,Chunlin Xiao,Eric Donaldson,Fritz J. Sedlazeck,Gary P. Schroth,Gökhan Yavaş,Haiying Grunenwald,Haodong Chen,Heather Meinholz,Joe Meehan,Jing Wang,Jingcheng Yang,Jonathan Foox,Jun Shang,Kelci Miclaus,Dong Li,Leming Shi,Marghoob Mohiyuddin,Mehdi Pirooznia,Ping Gong,Rooz Golshani,Russ Wolfinger,Samir Lababidi,Sayed Mohammad Ebrahim Sahraeian,Stephen T. Sherry,Tao Han,Tao Chen,Tieliu Shi,Wanwan Hou,Weigong Ge,Wen Zou,Wenjing Guo,Wenjun Bao,Wenzhong Xiao,Xiaohui Fan,Yoichi Gondo,Ying Yu,Yongmei Zhao,Zhenqiang Su,Zhichao Liu,Weida Tong,Wenming Xiao,Justin M. Zook,Yuanting Zheng,Huixiao Hong

DOI: https://doi.org/10.6084/m9.figshare.17798258

2022-01-01

Abstract:Additional file 10: Table S9. Factor contribution analysis by boosted tree.

Additional File 11 of A Novel Virtual Barcode Strategy for Accurate Panel-Wide Variant Calling in Circulating Tumor DNA

Additional File 13 of A Novel Virtual Barcode Strategy for Accurate Panel-Wide Variant Calling in Circulating Tumor DNA

A novel virtual barcode strategy for accurate panel-wide variant calling in circulating tumor DNA

Additional File 1 of Patient Specific Circulating Tumor DNA Fingerprints to Monitor Treatment Response Across Multiple Tumors

Additional File 6 of Mapping Intron Retention Events Contributing to Complex Traits Using Splice Quantitative Trait Locus

Additional File 5: of SeqCNV: a Novel Method for Identification of Copy Number Variations in Targeted Next-Generation Sequencing Data

Additional File 7: of CloneCNA: Detecting Subclonal Somatic Copy Number Alterations in Heterogeneous Tumor Samples from Whole-Exome Sequencing Data

Additional File 6 of CUBIC: an Atlas of Genetic Architecture Promises Directed Maize Improvement

A Novel Approach to Detect Large Indels from Targeted Sequencing Data in Clinical Cancer Setting

Additional File 4 of Clonal Evolution in Liver Cancer at Single-Cell and Single-Variant Resolution

Additional File 3 of Features of Alternative Splicing in Stomach Adenocarcinoma and Their Clinical Implication: a Research Based on Massive Sequencing Data

Figure S14 from Discovery and Features of an Alkylating Signature in Colorectal Cancer

Additional File 4 of A Next-Generation Sequencing-Based Strategy Combining Microsatellite Instability and Tumor Mutation Burden for Comprehensive Molecular Diagnosis of Advanced Colorectal Cancer

Additional File 8: of Genomic Copy Number Variation Association Study in Caucasian Patients with Nonsyndromic Cryptorchidism

Additional File 2 of Characterizing Sensitivity and Coverage of Clinical WGS As a Diagnostic Test for Genetic Disorders

Additional File 3 of CICERO: a Versatile Method for Detecting Complex and Diverse Driver Fusions Using Cancer RNA Sequencing Data

Copy number variation analysis based on AluScan sequences

Additional File 8 of Breast Metastatic Tumors in Lung Can Be Substituted by Lung-Derived Malignant Cells Transformed by Alternative Splicing H19 Lncrna

Additional File 2: of Evaluation of Three Read-Depth Based CNV Detection Tools Using Whole-Exome Sequencing Data

Additional File 5 of Genome-wide Characterization of Copy Number Variations in the Host Genome in Genetic Resistance to Marek’s Disease Using Next Generation Sequencing

Additional File 10 of Assessing Reproducibility of Inherited Variants Detected with Short-Read Whole Genome Sequencing